Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Annelise Capossela/Axios
Moderna has joined Pfizer in approaching the vaccine finish line, with a vaccine candidate the company says was 94.5% effective at preventing infection. Pfizer's candidate, announced last week, was over 90%.
Why it matters: There could be two U.S. vaccines in distribution before the New Year. This is a reason for Americans to buckle down for one last stretch to help save lives.
- There are a million new cases nationwide in the past six days alone.
- U.S. deaths are once again over 1,000 a day.
- Hospitals are filling up and health workers are stretched thin.
Now there's hope: The two companies plan to apply for emergency-use authorization later this month, and they could begin to immunize 20 million people as soon as December.
- Health care workers are at the top of the list, followed by essential workers, people with high-risk medical conditions and senior citizens.
- The general public could be offered the vaccine as soon as April, Dr. Anthony Fauci said today.
- "This does not mean that in April, everybody who’s going to be wanting a vaccine who’s not in the priority group is going to get it. It means starting at that point, you would likely begin to use those," he said.
Between the lines: Moderna’s vaccine can be kept in standard freezer storage for up to six months and refrigerators for up to 30 days — unlike Pfizer's candidate, which needs to be stored at ultra-cold temperatures.
The bottom line: Governors would ultimately have the final say of how to roll out the vaccine in their states.
- New York Gov. Andrew Cuomo (D) this morning: “This vaccination process has not been thought through at all. ... They're now saying we're going to do vaccines and distribution. You start off with a very high level of skepticism among the general population. That's 50% that don't trust the vaccine."
Go deeper: Axios Re:Cap interviewed Moderna's chief medical officer on its blockbuster vaccine news. Listen here.